FALLOPIAN TUBE CANCER

Clinical trials for FALLOPIAN TUBE CANCER explained in plain language.

Never miss a new study

Get alerted when new FALLOPIAN TUBE CANCER trials appear

Sign up with your email to follow new studies for FALLOPIAN TUBE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 31 Not yet recruiting 1 Not yet finished but already full! 19 Completed 13 Terminated 4

New hope for hard-to-treat ovarian cancer: experimental drug BL-M07D1 enters final testing phase

Disease control Not yet recruiting

This study tests a new drug called BL-M07D1 against standard chemotherapy in about 404 people with HER2-positive ovarian, fallopian tube, or peritoneal cancer that no longer responds to platinum-based treatments. The goal is to see if BL-M07D1 can slow cancer growth or improve su…

Matched conditions: FALLOPIAN TUBE CANCER

Phase: PHASE3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated May 15, 2026 11:56 UTC

FALLOPIAN TUBE CANCER

Get alerted when new FALLOPIAN TUBE CANCER trials appear

New hope for hard-to-treat ovarian cancer: experimental drug BL-M07D1 enters final testing phase